Date | Name | Shares | Transaction | Value |
Mar 24, 2025
| Christopher P. Comparato Director |
234,796
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $1.52 per share |
356,889.92
|
Mar 24, 2025
| Stephen Fredette President; Director |
359,327
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $35.14 per share |
12,626,750.78
|
Mar 24, 2025
| Stephen Fredette President; Director |
1,447,717
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $35.15 per share |
50,887,252.55
|
Mar 24, 2025
| Christopher P. Comparato Director |
565,000
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 24, 2025
| Stephen Fredette President; Director |
2,121,451
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $35.14 per share |
74,547,788.14
|
Mar 24, 2025
| Stephen Fredette President; Director |
1,402,132
| Bona fide gift |
0.00
|
Mar 24, 2025
| Christopher P. Comparato Director |
164,796
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $35.71 per share |
5,884,865.16
|
Mar 17, 2025
| Deval L. Patrick Director |
13,260
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $33.01 per share |
437,712.60
|
Mar 12, 2025
| Stephen Fredette President; Director |
2,253,342
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $33.78 per share |
76,117,892.76
|
Mar 12, 2025
| Stephen Fredette President; Director |
402,769
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $33.8 per share |
13,613,592.20
|
Mar 12, 2025
| Jonathan Vassil Chief Revenue Officer |
54,875
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 12, 2025
| Jonathan Vassil Chief Revenue Officer |
100,898
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 12, 2025
| Gail A. Miller Principal Accounting Officer |
90,544
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 12, 2025
| Stephen Fredette President; Director |
414,935
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $32.61 per share |
13,531,030.35
|
Mar 12, 2025
| Stephen Fredette President; Director |
393,613
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $34.64 per share |
13,634,754.32
|
Mar 12, 2025
| Elena Castanada Gomez President, CFO |
75,454
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 12, 2025
| Aman Narang CEO; Director |
137,189
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 12, 2025
| Aman Narang CEO; Director |
252,246
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 12, 2025
| Stephen Fredette President; Director |
2,224,309
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $34.63 per share |
77,027,820.67
|
Mar 12, 2025
| Elena Castanada Gomez President, CFO |
138,735
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|